BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 21, 2008

View Archived Issues

Paclitaxel-coated angioplasty balloons evaluated in leg angioplasty

Read More

Results of cardiac safety study of cethromycin reported

Read More

Spectrum receives Canadian approval to initiate phase III trials of EOquin for bladder cancer

Read More

Dosing begins in second phase III trial of CollaRx gentamicin for surgical site infections

Read More

USAMRIID study finds nanoviricides highly effective against Ebola virus

Read More

Recent Replidyne and Iqur patents disclose novel antiinfective agents

Read More

Novel therapeutic agents for dermatological disorders imparted in recent Maruzen patent

Read More

New therapeutic agents for viral hepatitis reported in recent Gilead patents

Read More

Phase II studies show promise of OGX-011 in prostate cancer

Read More

Data on UK-453061 in vitro activity, safety and potential for interactions reported

Read More

Phase I study finds picoplatin plus docetaxel safe in hormone-refractory prostate cancer

Read More

Mixed results seen with PI-88-docetaxel in hormone-refractory prostate cancer

Read More

Abiraterone active in phase I and II studies in castration-resistant prostate cancer

Read More

Encysive to be acquired by Pfizer

Read More

Additional orphan drug status granted to Marshall Edwards' triphendiol

Read More

Daiichi Sankyo and Lilly submit MAA to EMEA for prasugrel

Read More

Positive phase II data reported for ALN-RSV01 in RSV infection

Read More

Quest Diagnostics to develop blood test to aid in the detection of colorectal cancer

Read More

Cleveland Clinic initiates validation trial of SQI Diagnostics' SQiDworks platform

Read More

Biolex and Merck KGaA enter agreement to evaluate LEX System for antibody optimization

Read More

Northwest Biotherapeutics reports data from phase I/II clinical trials of DCVax-Brain

Read More

Sucampo Pharmaceuticals expands European presence

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 3, 2026.
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Liver over digital lens background

    EASL 2026: Emerging liver disease targets to watch

    BioWorld
    At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
  • Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

    ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

    BioWorld
    Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing